Immunome Inc. — Investor Relations & Filings
Immunome Inc. is a clinical-stage oncology company focused on developing targeted therapies to improve outcomes for cancer patients. The company specializes in creating first-in-class and best-in-class therapeutic candidates, with a primary focus on Antibody-Drug Conjugates (ADCs) and Radioligand Therapies (RLTs). Immunome utilizes a systematic, data-driven process to optimize each component of its drug candidates—antibody, linker, and payload—to address high unmet medical needs. Its clinical pipeline includes varegacestat, a gamma secretase inhibitor in a Phase 3 trial for desmoid tumors; IM-1021, a ROR1-targeted ADC in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand. The company also advances a portfolio of preclinical ADCs targeting various solid tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Immunome Inc. (0001472012) (Filer) | 2026-04-24 | English | |
| SCHEDULE 13G/A - Immunome Inc. (0001472012) (Subject) | 2026-03-26 | English | |
| 4 - Immunome Inc. (0001472012) (Issuer) | 2026-03-24 | English | |
| 144 - Immunome Inc. (0001472012) (Subject) | 2026-03-20 | English | |
| 10-K - IMMUNOME INC. (0001472012) (Filer) | 2026-03-03 | English | |
| 8-K - IMMUNOME INC. (0001472012) (Filer) | 2026-03-03 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 36260617 | ARS - Immunome Inc. (0001472012) (Filer) | 2026-04-24 | English | ||
| 33050365 | SCHEDULE 13G/A - Immunome Inc. (0001472012) (Subject) | 2026-03-26 | English | ||
| 33017259 | 4 - Immunome Inc. (0001472012) (Issuer) | 2026-03-24 | English | ||
| 33000829 | 144 - Immunome Inc. (0001472012) (Subject) | 2026-03-20 | English | ||
| 32892309 | 10-K - IMMUNOME INC. (0001472012) (Filer) | 2026-03-03 | English | ||
| 32892308 | 8-K - IMMUNOME INC. (0001472012) (Filer) | 2026-03-03 | English | ||
| 29982218 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
|
2025
8 filings
| |||||
| 12302604 | Director's Dealing 2025 | 2025-12-31 | English | ||
| 12302605 | Director's Dealing 2025 | 2025-12-23 | English | ||
| 12302609 | Major Shareholding Notification 2025 | 2025-12-23 | English | ||
| 12302606 | Director's Dealing 2025 | 2025-12-22 | English | ||
| 12302607 | Director's Dealing 2025 | 2025-12-22 | English | ||
| 12302608 | Director's Dealing 2025 | 2025-12-22 | English | ||
| 12302610 | Director's Dealing 2025 | 2025-12-18 | English | ||
| 12302611 | 8-K | 2025-12-17 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cellectar Biosciences, Inc.
Clinical-stage biopharma developing targeted cancer treatme…
|
CLRB | US | Manufacturing |
|
Cellectis
Develops allogeneic, or 'off-the-shelf', CAR T-cell immunot…
|
ALCLS | FR | Manufacturing |
|
Cellid Co., Ltd.
Develops immunotherapeutic vaccines for cancer and infectio…
|
299660 | KR | Manufacturing |
|
Cellromax Science Co., Ltd.
Researches and develops health foods, derma-cosmetics, and …
|
471820 | KR | Manufacturing |
|
CellSeed Inc.
Develops and commercializes cell sheet engineering for rege…
|
7776 | JP | Manufacturing |
|
Celltrion, Inc.
Biopharmaceutical firm developing biosimilars for autoimmun…
|
068270 | KR | Manufacturing |
|
Celltrion Pharm Inc.
Manufactures and supplies chemical pharmaceuticals and bios…
|
068760 | KR | Manufacturing |
|
CELLUMED CO., LTD.
Develops and manufactures medical devices, tissue grafts, a…
|
049180 | KR | Manufacturing |
|
Celon Pharma S.A.
An integrated pharmaceutical company researching and manufa…
|
CLN | PL | Manufacturing |
|
Celularity Inc
Develops allogeneic cell therapies and biomaterials from th…
|
CELU | US | Manufacturing |
Immunome Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32238/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32238 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32238 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32238 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32238}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Immunome Inc. (id: 32238)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.